The 8th China-Russia Expo will soon be held at the Harbin International Convention and Exhibition Center in Heilongjiang Province, along with the 33rd Harbin International Economic and Trade Fair.May 17th will be the Professional Visitors Day and May 18th to 21st will be the Public Open House.
This year's exposition to "cooperation, mutual trust, opportunity" as the theme of the exhibition covers a total area of 388,000 square meters, set up in Harbin International Convention and Exhibition Center, the main venue and Harbin Xilong market and other four sub-venues.The main venue has five exhibition areas, including Russia, international, Hong Kong, Macao and Taiwan, and is expected to exhibit more than 5,000 kinds of products in 10 fields and 20 categories.
Russian President Vladimir Putin will visit Harbin on May 16-17 and attend the opening ceremony of the 8th China-Russia Expo, according to news reports.
Bio-economy is the future direction of science and technology innovation and industrial economic development, Heilongjiang Province has the advantages of resources, innovation, industry and application scenarios for the development of bio-economy, and possesses a strong development foundation and great potential for development.
The Bio-economy Exhibition Hall of this year's HACCP takes "Bio-economy, Leading the Future" as the theme of the exhibition, and the middle section displays the R&D achievements of biomedicine, biomanufacturing and other industries.Among them, Dayou Unicorn Enterprise focuses on displaying the latest R&D results of the pharmaceutical auxiliary material segment - plant-based material hollow capsule project, which has obtained a number of international and domestic invention patents, and will soon be landed and implemented in Heilongjiang to further promote the development and upgrading of the bio-economy.
We sincerely invite all guests from all walks of life to attend this exposition, and look forward to working with you to support the construction of a new high ground for the bio-economy industry, to promote industrial innovation and development, and to create a benchmark in the field of pharmaceutical excipients.To build a new platform for high-level cooperation, promote international exchanges and cooperation, and broaden the development space and opportunities in the field of bio-economy.Write a new chapter of high-quality development and contribute wisdom and strength to the prosperity and development of the bio-economy industry.
Dayou Unicorn (Shanghai) Pharmaceutical Technology Co., Ltd. is a science and technology enterprise dedicated to the research and development, production and sales of pharmaceutical excipients segment, which is a holding subsidiary of DAYOU.The company has obtained a number of domestic and international patent authorization, covering the formula, process, equipment and its matching manufacturing environment conditions, forming a variety of patents, proprietary technology, copyright combination of independent intellectual property protection system.
The product manufacturing process adopts the original process technology means, combined with digitalization, informationization, high-end intelligent full servo production line.Constructed into a real meaning of "formula, equipment, process, environment" four-in-one quality control model, has a very high technical barriers.The products have passed the FDA certification and Halal certification in the U.S., and passed the drug-related review in China in 2023, and the products are mainly exported to the international market.
